Solving Barriers to Medication Access: How Pharmacies Can Improve Access Without Slowing Down Payments

Getting a prescription from a provider's pen to a patient's hands should be straightforward. In practice, it rarely is. Between prior authorization delays, cost barriers, transportation challenges, fragmented systems and a pharmacy landscape that is increasingly stretched, the journey from prescription to therapy is interrupted more often than most patients or pharmacy teams would like to admit.

The data from 2025 and 2026 makes the scale of the problem clear. The AMA's 2025 Prior Authorization Physician Survey found that 95% of physicians say PA delays access to necessary care and 79% report that patients abandon treatment because of it. A DrFirst 2025 survey of 1,000 patients found that more than half reported needing to take extra steps to obtain their medications and one third said delays led to worse health outcomes. According to IQVIA's 2026 US Medicine Use Trends report, nearly two-thirds of prescriptions for newly launched drugs go unfilled in the first year on the market.

For pharmacy owners, these barriers are not abstract policy problems. They are operational realities that play out at the counter and at the point of delivery every single day. This post identifies the most significant barriers to medication access that pharmacies are navigating in 2026 and offers practical solutions that address them without creating new problems for cash flow or compliance.

The most significant barriers to medication access in 2026

Prior authorization delays

Prior authorization remains the most consistently cited barrier to medication access across every stakeholder group. The AMA's 2025 Prior Authorization Physician Survey, released in May 2026, found that 95% of physicians say the prior authorization process delays necessary patient care, 92% say it negatively affects clinical outcomes and 80% report patients paying out of pocket for medications because PA delays and denials left them with no other option.

For pharmacies, the PA burden manifests as a specific set of operational problems: prescriptions that sit in a pending state while authorization is sought, patients who call repeatedly for updates and in some cases prescriptions that are simply abandoned before the authorization is resolved. The pharmacy is often the last point of contact before a patient gives up on a medication entirely.

Cost and affordability barriers

Out-of-pocket costs remain one of the most powerful drivers of medication non-adherence and prescription abandonment. The PAN Foundation's 2025 State of Patient Access report found that more than one in five patients reported prescriptions were not affordable and almost half of insured patients reported facing some form of insurance-related barrier to accessing their medications. One in five said they could not get the prescription they needed because of cost, putting their health at risk.

According to a KFF 2024 poll, 28% of adults struggle to pay for their prescription drugs, rising to 37% for those taking four or more medications. Many patients arrive at the pharmacy counter without knowing what their co-pay will be and when the figure is higher than expected, abandonment at the point of collection is a common outcome. Patient support programs exist to help bridge this gap but awareness remains low, making the pharmacist one of the most important touchpoints for connecting patients with affordability options.

Transportation and access barriers

The wave of pharmacy closures in 2025 deepened the crisis of pharmacy deserts, where residents face significant barriers to obtaining medications. For patients in rural areas, elderly patients with limited mobility and patients without reliable transportation, getting to a pharmacy is a genuine and recurring logistical challenge that compounds with every refill cycle.

For these patients, the barrier to medication access is not prior authorization or cost. It is physical distance and the inability to bridge it reliably. Home delivery addresses this barrier directly and for pharmacies serving patient populations with high proportions of elderly or rural patients, it is increasingly a clinical necessity rather than a service add-on.

Fragmented systems and information gaps

Industry fragmentation across providers, pharmacies and health plans creates data silos and workflow inefficiencies that patients absorb as delays and confusion. The AMA's 2025 survey found that 92% of physicians say prior authorization negatively affects clinical outcomes and that physicians complete an average of 39 PA requests per week, spending 13 hours on the process. The patient who falls between the gaps of these fragmented systems, receiving conflicting information from their provider, their insurer and their pharmacy, is the patient most likely to abandon their prescription or delay treatment.

How pharmacies can improve access without slowing down payments

Make home delivery a front-line access solution

For patients whose primary barrier is transportation or mobility, home delivery is the most direct and effective intervention a pharmacy can make. Proactively identifying patients who would benefit from delivery and enrolling them in a managed delivery program removes the access barrier at its root rather than trying to work around it. RxMile's pharmacy delivery software helps pharmacies build and scale delivery programs that are operationally efficient and compliance-ready from day one.

Remove financial friction at the point of delivery

For patients whose barrier is cost uncertainty or co-pay affordability, removing financial friction from the point of collection can significantly reduce abandonment rates. Enabling co-pay collection at the point of delivery, rather than requiring advance payment or post-delivery billing, allows patients to pay when their medication arrives. RxMile's co-pay collection tools integrate directly into the delivery workflow, making payment collection straightforward for drivers and patients alike and capturing revenue that would otherwise be lost to abandoned deliveries.

Proactively connect patients with affordability support

Out-of-pocket cost barriers and low awareness of patient support programs mean many patients who could access financial assistance never do. Pharmacists are among the best-positioned healthcare professionals to close that gap. A brief, consistent check at the point of dispensing for patients whose co-pay may be a barrier, particularly for brand medications or specialty drugs, can connect patients with manufacturer assistance programs or alternative coverage options that keep them on therapy.

Improve proactive communication around prescription status

One of the most damaging access barriers from the patient's perspective is not knowing what is happening with their prescription. Patients who are waiting on a prior authorization, a drug shortage resolution or a delivery window and receive no proactive communication are far more likely to abandon their prescription or switch to a competitor than patients who are kept informed throughout. Building proactive communication touchpoints into the prescription and delivery workflow reduces patient anxiety, reduces inbound calls and reduces the likelihood that a delay becomes an abandonment.

Balancing access improvements with payment integrity

A concern that sometimes surfaces when pharmacies consider expanding access initiatives is whether the operational investment required will create cash flow pressure or compliance risk. The short answer is that it does not have to, provided the right systems are in place.

Home delivery, when built on a platform that captures proof of delivery, chain of custody documentation and patient signatures at the point of delivery, generates the same audit-ready compliance record as an in-store dispensing transaction. Co-pay collection at the point of delivery, when handled through an integrated platform rather than informal cash arrangements, captures revenue cleanly and creates a clear payment record. Proactive patient communication, when delivered through a system rather than managed manually, does not add to staff workload.

The pharmacies that have successfully expanded access without compromising payment performance are those that have invested in the operational infrastructure to make access initiatives scalable and compliant from the start, rather than building them informally and retrofitting compliance later.

Access and operational performance are not in conflict

The barriers to medication access that patients face in 2026 are real, well-documented and consequential. Prior authorization delays, cost barriers, transportation challenges and fragmented information systems all contribute to a landscape where too many patients do not complete the journey from prescription to therapy.

Pharmacies are not responsible for all of these barriers and they cannot solve all of them alone. But for several of the most impactful access gaps, the pharmacy is the closest and most trusted point of intervention available. Home delivery, co-pay support at the point of delivery and proactive patient communication are all interventions that sit within the pharmacy's operational reach and can be implemented without undermining payment performance or creating compliance risk.

RxMile's prescription delivery software gives pharmacies the complete platform to build delivery programs that improve patient access, capture co-pay revenue reliably and generate audit-ready compliance records with every delivery. Start your 30-day free trial today.